prikaz prve stranice dokumenta Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells
No public access
Scientific paper - Original scientific paper
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells
Cancer Gene Therapy, 29 (2022), 11; 1676-1685. https://doi.org/10.1038/s41417-022-00486-x

Zaffran, Ilan; Landolina, Nadine; Gaur, Pratibha; Lenac Roviš, Tihana; Jonjić, Stipan; Mandelboim, Ofer; Singer, Bernhard B.; Levi-Schaffer, Francesca

Cite this document

Zaffran, I., Landolina, N., Gaur, P., Lenac Roviš, T., Jonjić, S., Mandelboim, O. ... Levi Schaffer, F. (2022). Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer Gene Therapy, 29. (11), 1676-1685. doi: 10.1038/s41417-022-00486-x

Zaffran, Ilan, et al. "Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells." Cancer Gene Therapy, vol. 29, no. 11, 2022, pp. 1676-1685. https://doi.org/10.1038/s41417-022-00486-x

Zaffran, Ilan, Nadine Landolina, Pratibha Gaur, Tihana Lenac Roviš, Stipan Jonjić, Ofer Mandelboim, Bernhard B. Singer and Francesca Levi Schaffer. "Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells." Cancer Gene Therapy 29, no. 11 (2022): 1676-1685. https://doi.org/10.1038/s41417-022-00486-x

Zaffran, I., et al. (2022) 'Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells', Cancer Gene Therapy, 29(11), pp. 1676-1685. doi: 10.1038/s41417-022-00486-x

Zaffran I, Landolina N, Gaur P, Lenac Roviš T, Jonjić S, Mandelboim O, and sur.. Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer Gene Therapy [Internet]. 2022 June 09 [cited 2024 June 25];29(11):1676-1685. doi: 10.1038/s41417-022-00486-x

I. Zaffran, et al., "Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells", Cancer Gene Therapy, vol. 29, no. 11, pp. 1676-1685, June 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:520126. [Accessed: 25 June 2024]